Recruiting

Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease

Prospective, observational study to define precipitants and predictors of development of Acute-on-Chronic Liver Failure (ACLF) after surgical interventions, allowing to develop a risk stratification for elective procedures in cirrhotic patients. As well as identifying molecular mechanisms of post-interventional ACLF and thus preparing the ground for development of new therapeutic approaches.

I'm interested View official listing
ClinicalTrials.gov IDNCT04578301
PhaseNot Applicable
Enrollment200
SponsorUniversity Hospital, Bonn
Age18 Years and older
SexALL
I'm interested View official listing

Conditions studied

Liver Cirrhosis, Portal Hypertension, Surgery, Acute-On-Chronic Liver Failure, Non-Cirrhotic Portal Hypertension

About this study

Prospective, observational study to define precipitants and predictors of development of Acute-on-Chronic Liver Failure (ACLF) after surgical interventions, allowing to develop a risk stratification for elective procedures in cirrhotic patients. As well as identifying molecular mechanisms of post-interventional ACLF and thus preparing the ground for development of new therapeutic approaches.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Male or female adult (≥18 years) patient * With or without liver cirrhosis (diagnosed either histologically or by a combination of clinical, laboratory and radiological signs) * Or Non-cirrhotic portal hypertension * Non-pregnant, non-lactating females * Ability to understand the patient information and to personally sign and date the informed consent to participate in the study * The patient is co-operative and available for the entire study * Provided written informed consent * Indication for surgical intervention Exclusion Criteria: * Pregnant or lactating females * Patients undergoing surgery as form of palliative cancer therapy * Presence or history of severe extra-hepatic diseases * HIV-positive patients * Previous liver or other transplantation * Patients with acute or subacute liver failure without underlying cirrhosis * Patients who decline to participate * Physician´s denial (e.g. the investigator considers that the patient will not follow the protocol scheduled)

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-13.